Kent Tegeler
Liberty, MONPI 1760481139
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $551 and has fallen 97.0% since, to $16 in 2024.
Across 108 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$371
- AbbVie$359
- Amgen$192
- Coopersurgical, Inc.$190
- Astellas Pharma US Inc$176
- Intuitive Surgical$143
- plus $728 from 17 others
What the payments were for
- Food & beverage$2,14799%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 26 | $371 |
| AbbVie(2 entities) | 19 | $359 |
| Amgen | 12 | $192 |
| Coopersurgical, Inc. | 5 | $190 |
| Astellas Pharma US Inc | 10 | $176 |
| Intuitive Surgical | 3 | $143 |
| Channel Medsystems, Inc. | 2 | $139 |
| Therapeuticsmd, Inc. | 6 | $91 |
| Johnson & Johnson | 1 | $86 |
| Medtronic | 1 | $68 |
| Mayne Pharma Commercial LLC | 5 | $62 |
| Organon | 4 | $60 |
| Bayer | 2 | $45 |
| Pacira Pharmaceuticals Incorporated | 1 | $32 |
| Evofem Biosciences, Inc. | 2 | $27 |
| Avion Pharmaceuticals | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Boston Scientific | 1 | $14 |
| Minerva Surgical, Inc | 1 | $14 |
| Bsn Medical Inc | 1 | $12 |
| Lupin Inc. | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Covidien LP | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Paragard$113
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 29 | $512 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.